全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

A Multimodal Machine-Learning Framework for Predicting Lithium-Associated Renal Dysfunction from Synthetic Biomarker Trajectories

DOI: 10.4236/oalib.1114919, PP. 1-27

Subject Areas: Artificial Intelligence, Nephrology

Keywords: Lithium Nephrotoxicity, Machine Learning, Synthetic Clinical Data, Kidney Function Modelling, eGFR Decline Prediction, SHAP Interpretability, Biomedical Risk Stratification, Renal Biomarker Dynamics

Full-Text   Cite this paper   Add to My Lib

Abstract

Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant risk of progressive renal impairment in a subset of patients. Early recognition of individuals vulnerable to lithium-associated nephrotoxicity is clinically critical but challenging, given the heterogeneous evolution of renal biomarkers, nonlinear exposure effects, and complex interactions with comorbidities and concomitant medications. In this work, we introduce a multimodal machine-learning framework built on a mathematically transparent generator of synthetic renal tra-jectories. The simulator parameterizes baseline kidney function, lithium burden, hydration status, and comorbidity load to produce physiologically coherent serum and urine biomarker patterns over time. Using these synthetic trajectories, we train an ensemble of classical and gradient-boosted classifiers that achieve near-perfect discrimination of nephrotoxicity (AUC ≈ 1.00) on held-out data. Across models, biologically interpretable predictors including creatinine elevation, eGFR decline, and cumulative lithium load emerge consistently as dominant risk factors. Subgroup analyses confirm stable performance across age, sex, BMI, and serum-lithium strata, while SHAP explainability reveals mechanistic relationships linking lithium exposure, filtration dynamics, and acute renal stress. Together, these results demonstrate how structured synthetic data and interpretable multimodal machine learning can form a high-fidelity experimental testbed for studying lithium’s renal effects and for prototyping clinically actionable early-detection tools.

Cite this paper

Filippis, R. D. and Foysal, A. A. (2026). A Multimodal Machine-Learning Framework for Predicting Lithium-Associated Renal Dysfunction from Synthetic Biomarker Trajectories. Open Access Library Journal, 13, e14919. doi: http://dx.doi.org/10.4236/oalib.1114919.

References

[1]  Airainer, M. and Seifert, R. (2024) Lithium, the Gold Standard Drug for Bipolar Disorder: Analysis of Current Clinical Studies. Naunyn-Schmiedeberg’s Archives of Pharmacology, 397, 9723-9743. https://doi.org/10.1007/s00210-024-03210-8
[2]  Gitlin, M. and Bauer, M. (2024) Lithium: Current State of the Art and Future Directions. International Journal of Bipolar Disorders, 12, Article No. 40. 
https://doi.org/10.1186/s40345-024-00362-7
[3]  Bauer, M. and Gitlin, M. (2016) The Essential Guide to Lithium Treatment. Springer International Pub-lishing.
[4]  Sani, G., Perugi, G. and Tondo, L. (2017) Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice? Clinical Drug Investigation, 37, 713-727. https://doi.org/10.1007/s40261-017-0531-2
[5]  Song, J. (2017) Bipolar Disorder and Lithium Treatment: Etiologies and Consequences. Ph.D. Thesis, Karolinska Institutet.
[6]  Slots, J. and Rams, T.E. (1990) Antibiotics in Perio-dontal Therapy: Advantages and Disadvantages. Journal of Clinical Periodon-tology, 17, 479-493. 
https://doi.org/10.1111/j.1365-2710.1992.tb01220.x
[7]  Alaoui Mdarhri, H., Benmessaoud, R., Yacoubi, H., Seffar, L., Guennouni Assimi, H., Hamam, M., et al. (2022) Alternatives Therapeutic Approaches to Conventional Antibiotics: Advantages, Limitations and Potential Application in Medicine. Antibiotics, 11, Article 1826. https://doi.org/10.3390/antibiotics11121826
[8]  Fellström, B., Jardine, A.G., Soveri, I., Cole, E., Neumayer, H.‐H., Maes, B., et al. (2005) Renal Dysfunction Is a Strong and Independent Risk Factor for Mortality and Cardio-vascular Complications in Renal Transplantation. American Journal of Trans-plantation, 5, 1986-1991. https://doi.org/10.1111/j.1600-6143.2005.00983.x
[9]  Morello, J. and Bichet, D.G. (2001) Nephrogenic Diabetes Insipidus. Annual Review of Physiol-ogy, 63, 607-630. https://doi.org/10.1146/annurev.physiol.63.1.607
[10]  Bichet, D.G. (2006) Nephrogenic Diabetes Insipidus. Advances in Chronic Kidney Disease, 13, 96-104. https://doi.org/10.1053/j.ackd.2006.01.006
[11]  Murray, T. and Goldberg, M. (1975) Chronic Interstitial Nephritis: Etiologic Factors. Annals of Internal Medicine, 82, 453-459. 
https://doi.org/10.7326/0003-4819-82-4-453
[12]  Vistisen, D., Andersen, G.S., Hulman, A., Persson, F., Rossing, P. and Jørgensen, M.E. (2019) Progres-sive Decline in Estimated Glomerular Filtration Rate in Patients with Diabetes after Moderate Loss in Kidney Function—Even without Albuminuria. Diabetes Care, 42, 1886-1894. https://doi.org/10.2337/dc19-0349
[13]  Chen, Y., Weng, S., Liu, J., Chuang, H., Hsu, C. and Tarng, D. (2017) Severe Decline of Es-timated Glomerular Filtration Rate Associates with Progressive Cognitive Dete-rioration in the Elderly: A Community-Based Cohort Study. Scientific Reports, 7, Article No. 42690. https://doi.org/10.1038/srep42690
[14]  Zhong, J., Yang, H. and Fogo, A.B. (2017) A Perspective on Chronic Kidney Disease Progression. American Journal of Physiology-Renal Physiology, 312, F375-F384. 
https://doi.org/10.1152/ajprenal.00266.2016
[15]  Eddy, A.A. (2005) Pro-gression in Chronic Kidney Disease. Advances in Chronic Kidney Disease, 12, 353-365. https://doi.org/10.1053/j.ackd.2005.07.011
[16]  Romagnani, P., Remuzzi, G., Glassock, R., Levin, A., Jager, K.J., Tonelli, M., et al. (2017) Chronic Kidney Disease. Nature Reviews Disease Primers, 3, 1-24. 
https://doi.org/10.1038/nrdp.2017.88
[17]  Dobler, C.C. (2021) Treatment Burden Is Important to Patients but Often Overlooked by Clinicians. Breathe, 17, Article 210031. 
https://doi.org/10.1183/20734735.0031-2021
[18]  Dickinson, L.M., Dickin-son, W.P., Rost, K., deGruy, F., Emsermann, C., Froshaug, D., et al. (2008) Clini-cian Burden and Depression Treatment: Disentangling Patient- and Clini-cian-Level Effects of Medical Comorbidity. Journal of General Internal Medicine, 23, 1763-1769. https://doi.org/10.1007/s11606-008-0738-2
[19]  Cocker, J., Mason, H.J., Warren, N.D. and Cotton, R.J. (2011) Creatinine Adjustment of Bi-ological Monitoring Results. Occupational Medicine, 61, 349-353. 
https://doi.org/10.1093/occmed/kqr084
[20]  da Cunha Santos, G., Shepherd, F.A. and Tsao, M.S. (2011) EGFR Mutations and Lung Cancer. Annual Review of Pathology: Mechanisms of Disease, 6, 49-69. 
https://doi.org/10.1146/annurev-pathol-011110-130206
[21]  Nolen, W.A., Licht, R.W., Young, A.H., Malhi, G.S., Tohen, M., Vieta, E., et al. (2019) What Is the Optimal Serum Level for Lithium in the Maintenance Treatment of Bipolar Disorder? A Systematic Review and Recommendations from the ISBD/IGSLI Task Force on Treatment with Lithium. Bipolar Disorders, 21, 394-409. 
https://doi.org/10.1111/bdi.12805
[22]  Anderson, S., Halter, J.B., Hazzard, W.R., Himmelfarb, J., Horne, F.M., Kaysen, G.A., et al. (2009) Prediction, Pro-gression, and Outcomes of Chronic Kidney Disease in Older Adults. Journal of the American Society of Nephrology, 20, 1199-1209. 
https://doi.org/10.1681/asn.2008080860
[23]  Delrue, C., De Bruyne, S. and Speeckaert, M.M. (2024) Application of Machine Learning in Chronic Kidney Disease: Current Status and Future Prospects. Biomedicines, 12, Article 568. https://doi.org/10.3390/biomedicines12030568
[24]  Kumar, R., Joseph, B., Pazdernik, V.M., Geske, J., Nuñez, N.A., Pahwa, M., Kashani, K.B., et al. (2023) Real-World Clinical Practice among Patients with Bipolar Disorder and Chronic Kidney Disease on Long-Term Lithium Therapy. Journal of Clinical Psycho-pharmacology, 43, 6-11. https://doi.org/10.1097/JCP.0000000000001632
[25]  Zhu, R., Vora, B., Menon, S., Younis, I., Dwivedi, G., Meng, Z., et al. (2023) Clinical Pharmacology Applications of Real‐World Data and Real‐World Evidence in Drug Development and Approval—An Industry Perspective. Clinical Pharmacology & Therapeutics, 114, 751-767. https://doi.org/10.1002/cpt.2988
[26]  Fox, M.A. and Dulay, M.T. (1993) Heterogeneous Photocatalysis. Chemical Reviews, 93, 341-357. https://doi.org/10.1021/cr00017a016
[27]  Kennell Jr., T.I., Willig, J.H. and Cimino, J.J. (2017) Clinical Informatics Researcher’s Desiderata for the Data Content of the Next Generation Electronic Health Record. Applied Clinical In-formatics, 8, 1159-1172.
https://doi.org/10.4338/ACI-2017-06-R-0101
[28]  Avolio, C., Tricomi, A., Mammone, C., Zavagli, M. and Costantini, M. (2019) A Deep Learning Architec-ture for Heterogeneous and Irregularly Sampled Remote Sensing Time Series. IGARSS 2019-2019 IEEE International Geoscience and Remote Sensing Sympo-sium, Yokohama, 28 July 2019-2 August 2019, 9807-9810. 
https://doi.org/10.1109/igarss.2019.8900467
[29]  Torchin, M.E., Miura, O. and Hechinger, R.F. (2015) Parasite Species Richness and Intensity of Interspe-cific Interactions Increase with Latitude in Two Wide‐Ranging Hosts. Ecology, 96, 3033-3042. https://doi.org/10.1890/15-0518.1
[30]  Barow, E., Probst, A., Pinnschmidt, H., Heinze, M., Jensen, M., Rimmele, D.L., et al. (2022) Effect of Comorbidity Burden and Polypharmacy on Poor Functional Outcome in Acute Ischemic Stroke. Clinical Neuroradiology, 33, 147-154. 
https://doi.org/10.1007/s00062-022-01193-8
[31]  Bjørk, E., Rentsch, C.T., Desai, R.J., Andersen, J.H., Lundby, C. and Pottegård, A. (2025) Polypharmacy’s Association with Mortality: Confounding from Underlying Morbidity. Journal of the American Geriatrics Society, 73, 2485-2493. 
https://doi.org/10.1111/jgs.19572
[32]  Kendler, K.S. (2016) The Nature of Psychiatric Disorders. World Psychiatry, 15, 5-12. https://doi.org/10.1002/wps.20292
[33]  Del Vecchio, L. and Locatelli, F. (2009) Ethical Issues in the Elderly with Renal Disease. Clinics in Geriatric Medicine, 25, 543-553. 
https://doi.org/10.1016/j.cger.2009.04.006
[34]  White, T., Blok, E. and Cal-houn, V.D. (2022) Data Sharing and Privacy Issues in Neuroimaging Research: Opportunities, Obstacles, Challenges, and Monsters under the Bed. Human Brain Mapping, 43, 278-291. https://doi.org/10.1002/hbm.25120
[35]  Denissen, S., Chen, O.Y., De Mey, J., De Vos, M., Van Schependom, J., Sima, D.M. and Nagels, G. (2021) Towards Multimodal Machine Learning Prediction of Individual Cognitive Evolution in Multiple Sclerosis. Journal of Personalized Medicine, 11, 1349. https://doi.org/10.3390/jpm11121349
[36]  Wu, E.Q., Royer, J., Leroux, M., Hossain, I. and Platt, R.W. (2025) CO144 Synthetic Patient Trajectories Using Generative AI on Electronic Health Records. Value in Health, 28, S49-S50. https://doi.org/10.1016/j.jval.2025.04.229
[37]  Lanyi, J.K. (1999) Progress toward an Explicit Mechanistic Model for the Light‐Driven Pump, Bacteriorho-dopsin. FEBS Letters, 464, 103-107. 
https://doi.org/10.1016/s0014-5793(99)01685-3
[38]  Black, A.J. and McKane, A.J. (2012) Stochastic Formulation of Ecological Models and Their Ap-plications. Trends in Ecology & Evolution, 27, 337-345. 
https://doi.org/10.1016/j.tree.2012.01.014
[39]  Huang, Y. and Gottardo, R. (2012) Comparability and Reproducibility of Biomedical Data. Briefings in Bio-informatics, 14, 391-401. https://doi.org/10.1093/bib/bbs078
[40]  Mosekilde, E., Sosnovtseva, O.V. and Holstein‐Rathlou, N. (2005) Mechanism‐Based Modeling of Complex Bio-medical Systems. Basic & Clinical Pharmacology & Toxicology, 96, 212-224. https://doi.org/10.1111/j.1742-7843.2005.pto960311.x
[41]  Roenneberg, T., Chua, E.J., Bernardo, R. and Mendoza, E. (2008) Modelling Biological Rhythms. Current Biology, 18, R826-R835. 
https://doi.org/10.1016/j.cub.2008.07.017
[42]  Schönfelder, S. (2006) Ur-ban Rhythms: Modelling the Rhythms of Individual Travel Behaviour. Ph.D. Thesis, ETH Zurich.
[43]  Marmor, J. (2021) Psychiatry in Transition. 2nd edi-tion, Routledge. 
https://doi.org/10.4324/9780429338397
[44]  Mutschler, C., Lichtenstein, S., Kidd, S.A. and Davidson, L. (2019) Transition Experiences Following Psychiatric Hospitalization: A Systematic Review of the Literature. Community Mental Health Journal, 55, 1255-1274. 
https://doi.org/10.1007/s10597-019-00413-9
[45]  Khalaf, A., Nabian, M., Fan, M., Yin, Y., Wormwood, J., Siegel, E., et al. (2020) Analysis of Multimodal Physiological Signals within and between Individuals to Predict Psychological Challenge vs. Threat. Expert Systems with Applications, 140, Article 112890. https://doi.org/10.1016/j.eswa.2019.112890
[46]  Zhang, X., Wei, X., Zhou, Z., Zhao, Q., Zhang, S., Yang, Y., et al. (2024) Dynamic Alignment and Fusion of Multimodal Physiological Patterns for Stress Recognition. IEEE Transactions on Affective Computing, 15, 685-696. 
https://doi.org/10.1109/taffc.2023.3290177
[47]  Oliveira, J.L.D., Silva Júnior, G.B.D., Abreu, K.L.S.D., Rocha, N.D.A., Franco, L.F.L.G., Araújo, S.M.H.A., et al. (2010) Nefrotoxicidade por lítio. Revista da Associação Médica Brasileira, 56, 600-606. 
https://doi.org/10.1590/s0104-42302010000500025
[48]  Grünfeld, J. and Rossier, B.C. (2009) Lithium Nephrotoxicity Revisited. Nature Reviews Neph-rology, 5, 270-276. https://doi.org/10.1038/nrneph.2009.43
[49]  Davis, J., Desmond, M. and Berk, M. (2018) Lithium and Nephrotoxicity: A Literature Re-view of Approaches to Clinical Management and Risk Stratification. BMC Neph-rology, 19, Article No. 305. https://doi.org/10.1186/s12882-018-1101-4
[50]  Staessen, J.A., Wang, J., Bianchi, G. and Birkenhäger, W.H. (2003) Essential hypertension. The Lancet, 361, 1629-1641. https://doi.org/10.1016/s0140-6736(03)13302-8
[51]  Egan, A.M. and Din-neen, S.F. (2019) What Is Diabetes? Medicine, 47, 1-4. 
https://doi.org/10.1016/j.mpmed.2018.10.002
[52]  Joki, N., Hase, H., Naka-mura, R. and Yamaguchi, T. (1997) Onset of Coronary Artery Disease Prior to Initiation of Haemodialysis in Patients with End-Stage Renal Disease. Nephrolo-gy Dialysis Transplantation, 12, 718-723. 
https://doi.org/10.1093/ndt/12.4.718
[53]  Chan, J.K.N., Solmi, M., Correll, C.U., Man Wong, C.S., Lo, H.K.Y., Lai, F.T.T., et al. (2025) Lithium for Bipolar Disorder and Risk of Thyroid Dysfunction and Chronic Kidney Disease. JAMA Network Open, 8, e2458608. 
https://doi.org/10.1001/jamanetworkopen.2024.58608
[54]  Darmon, M., Schnell, D. and Schneider, A. (2022) Monitoring of Renal Perfusion. Intensive Care Medicine, 48, 1505-1507. 
https://doi.org/10.1007/s00134-022-06857-0
[55]  Singh, B., Cusick, A.S., Goyal, A. and Patel, P. (2025) ACE Inhibitors. StatPearls Publishing.
[56]  Ejaz, P., Bhojani, K. and Joshi, V.R. (2004) NSAIDs and Kidney. Journal of the Associ-ation of Physicians of India, 52, 632-640.
[57]  Kudo, K., Konta, T., Mashima, Y., Ichikawa, K., Takasaki, S., Ikeda, A., et al. (2011) The Association between Renal Tubular Damage and Rapid Renal Deterioration in the Japanese Popula-tion: The Takahata Study. Clinical and Experimental Nephrology, 15, 235-241. https://doi.org/10.1007/s10157-010-0392-y
[58]  Hajek, T., Cullis, J., Novak, T., Kopecek, M., Höschl, C., Blagdon, R., et al. (2012) Hippocampal Volumes in Bipolar Disorders: Opposing Effects of Illness Burden and Lithium Treatment. Bipolar Disorders, 14, 261-270. 
https://doi.org/10.1111/j.1399-5618.2012.01013.x
[59]  Yokoyama, Y., Maruyama, K., Yamamoto, K., Omodaka, K., Yasuda, M., Himori, N., et al. (2014) The Role of Calpain in an in Vivo Model of Oxidative Stress-Induced Retinal Ganglion Cell Damage. Biochemical and Biophysical Research Communi-cations, 451, 510-515. https://doi.org/10.1016/j.bbrc.2014.08.009
[60]  Terrin, N., Schmid, C.H., Griffith, J.L., D’Agostino, R.B. and Selker, H.P. (2003) External Validity of Pre-dictive Models: A Comparison of Logistic Regression, Classification Trees, and Neural Networks. Journal of Clinical Epidemiology, 56, 721-729. 
https://doi.org/10.1016/s0895-4356(03)00120-3
[61]  Lee, J. (2017) Pa-tient-Specific Predictive Modeling Using Random Forests: An Observational Study for the Critically Ill. JMIR Medical Informatics, 5, e3. 
https://doi.org/10.2196/medinform.6690
[62]  Zhang, Z., Zhao, Y., Canes, A., Steinberg, D. and Lyashevska, O. (2019) Predictive Analytics with Gradient Boosting in Clinical Medicine. Annals of Translational Medicine, 7, 152-152. https://doi.org/10.21037/atm.2019.03.29
[63]  Yang, H., Chen, Z., Yang, H. and Tian, M. (2023) Predicting Coronary Heart Disease Using an Improved Lightgbm Model: Performance Analysis and Comparison. IEEE Access, 11, 23366-23380. https://doi.org/10.1109/access.2023.3253885
[64]  Wang, X., Zhu, T., Xia, M., Liu, Y., Wang, Y., Wang, X., et al. (2022) Predicting the Progno-sis of Patients in the Coronary Care Unit: A Novel Multi-Category Machine Learning Model Using Xgboost. Frontiers in Cardiovascular Medicine, 9, Article ID: 764629. https://doi.org/10.3389/fcvm.2022.764629
[65]  Botalb, A., Moinuddin, M., Al-Saggaf, U.M. and Ali, S.S.A. (2018) Contrasting Convolutional Neural Network (CNN) with Multi-Layer Perceptron (MLP) for Big Data Analy-sis. 2018 International Conference on Intelligent and Advanced System (ICIAS), Kuala Lumpur, 13-14 August 2018, 1-5. 
https://doi.org/10.1109/icias.2018.8540626
[66]  Sun, Z., Yu, D., Fang, H., Yang, J., Qu, X., Zhang, J., et al. (2020) Are We Evaluating Rigorously? Bench-marking Recommendation for Reproducible Evaluation and Fair Comparison. Fourteenth ACM Conference on Recommender Systems, Virtual Event, 22-26 September 2020, 23-32. https://doi.org/10.1145/3383313.3412489
[67]  Bizzego, A., Bussola, N., Chierici, M., Maggio, V., Francescatto, M., Cima, L., et al. (2019) Evaluating Re-producibility of AI Algorithms in Digital Pathology with Dapper. PLOS Computa-tional Biology, 15, e1006269. 
https://doi.org/10.1371/journal.pcbi.1006269
[68]  Hernández-Orallo, J., Flach, P. and Ferri, C. (2013) ROC Curves in Cost Space. Machine Learning, 93, 71-91. https://doi.org/10.1007/s10994-013-5328-9
[69]  Calders, T. and Jaroszewicz, S. (2007) Efficient AUC Optimization for Classification. In: Kok, J.N., Koronacki, J., Lopez de Mantaras, R., Matwin, S., Mladenič, D. and Skowron, A., Eds., Lecture Notes in Computer Science, Springer, 42-53. 
https://doi.org/10.1007/978-3-540-74976-9_8
[70]  Wang, S., Li, D., Petrick, N., Sahiner, B., Linguraru, M.G. and Summers, R.M. (2015) Optimizing Area under the ROC Curve Using Semi-Supervised Learning. Pattern Recognition, 48, 276-287. https://doi.org/10.1016/j.patcog.2014.07.025
[71]  Alba, A.C., Ago-ritsas, T., Walsh, M., Hanna, S., Iorio, A., Devereaux, P.J., et al. (2017) Discrimi-nation and Calibration of Clinical Prediction Models: Users’ Guides to the Medi-cal Literature. JAMA, 318, 1377-1384. https://doi.org/10.1001/jama.2017.12126
[72]  Taal, M.W. and Brenner, B.M. (2008) Renal Risk Scores: Progress and Prospects. Kidney International, 73, 1216-1219. https://doi.org/10.1038/ki.2008.36
[73]  Vearrier, D. and Grundmann, O. (2021) Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids. The Journal of Clinical Pharmacology, 61, S70-S88. 
https://doi.org/10.1002/jcph.1923
[74]  Breckenridge, A. (1996) A Clinical Pharmacologist’s View of Drug Toxicity. British Journal of Clinical Pharmacology, 42, 53-58. 
https://doi.org/10.1046/j.1365-2125.1996.03762.x
[75]  Sales, G.T.M. and Foresto, R.D. (2020) Drug-Induced Nephrotoxicity. Revista da Associação Mé-dica Brasileira, 66, s82-s90. https://doi.org/10.1590/1806-9282.66.s1.82
[76]  Barnett, L.M.A. and Cum-mings, B.S. (2018) Nephrotoxicity and Renal Pathophysiology: A Contemporary Perspective. Toxicological Sciences, 164, 379-390. 
https://doi.org/10.1093/toxsci/kfy159
[77]  Kwong, G.A., Ghosh, S., Gamboa, L., Patriotis, C., Srivastava, S. and Bhatia, S.N. (2021) Synthetic Biomarkers: A Twenty-First Century Path to Early Cancer Detection. Nature Reviews Cancer, 21, 655-668. 
https://doi.org/10.1038/s41568-021-00389-3
[78]  An, G. and Cockrell, C. (2023) Generating Synthetic Multi-Dimensional Molecular-Mediator Time Series Data for Artificial Intelligence-Based Disease Trajectory Forecasting and Drug Development Digital Twins: Considerations. arXiv:2303.09056.
[79]  Koratala, A. and Reisinger, N. (2021) POCUS for Nephrologists: Basic Principles and a General Approach. Kidney360, 2, 1660-1668. 
https://doi.org/10.34067/kid.0002482021
[80]  Amerling, R., Glezerman, I., Savransky, E., Dubrow, A. and Ronco, C. (2003) Interventional Nephrology and Dialysis: Continuous Flow Peritoneal Dialysis: Principles and Applications. Sem-inars in Dialysis, 16, 335-340. 
https://doi.org/10.1046/j.1525-139x.2003.16065.x
[81]  Mendelssohn, Da-vid, C., Barrett, B.J., Brownscombe, L.M., Ethier, J., Greenberg, D.E., Kanani, S.D., Levin, A. and Toffelmire, E.B. (1999) Elevated Levels of Serum Creatinine: Recommendations for Management and Referral. Canadian Medical Association Journal, 161, 413-417.

Full-Text


Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133